Independent fund research. Built on SEC filings.

How we research funds

ETF · Health Care Sector · Invesco

Invesco S&P SmallCap Health Care ETF (PSCH)

Ticker PSCH · Index fund · Since 2010-04-07 · · Holdings as of May 31, 2026

Expense ratio
0.29%$29/yr per $10k
5-yr return
+0.6%annualized
1-yr return
+3.8%as of Dec 2024
Net assets
$131.4Mall share classes
Holdings
81

Bottom line

Is PSCH a good fund? The bottom line

PSCH is an index health care sector ETF from Invesco.

Its expense ratio is 0.29% — about $29 a year on every $10,000 invested, cheaper than 94% of health care sector funds we track.

It returned +3.8% over one year, +0.6% a year over five years, +8.4% a year over ten (as of Dec 31, 2024, per its prospectus).

With $131 million in net assets and 81 holdings, its largest position is Invesco Private Prime Fund (21.5%) and the top 10 make up 59.8% of the portfolio.

What stands out

  • Low cost: cheaper than 94% of health care sector peers

What to watch

  • 5-year return in the bottom quarter of its category
  • Concentrated: top 10 holdings are 59.8% of assets

Updated Nov 19, 2026

What PSCH invests in

The Invesco S&P SmallCap Health Care ETF (the Fund) seeks to track the investment results (before fees and expenses) of the S&P SmallCap 600 Capped Health Care Index (the Underlying Index).

The Fund generally will invest at least 90% of its total assets in the securities that comprise the Underlying Index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices, LLC (the Index Provider) compiles, maintains and calculates the Underlying Index, which is designed to measure the performance of securities of small-capitalization U.S. companies in the health care sector, as defined by the Global Industry Classification Standard (GICS ). These companies are principally engaged in the business of providing healthcare-related products, facilities, technology, supplies, and equipment and services, including in areas such as biotechnology, pharmaceuticals and life sciences. The Underlying Index selects constituents from the S&P SmallCap 600 Index, which is comprised of common stocks of approximately 600 small-capitalization companies that generally…

From the fund's prospectus (filed Dec 18, 2025).

PSCH performance

Fund calendar-year total returns, 2015–2024 2015: +20.3%; 2016: +2.0%; 2017: +34.4%; 2018: +9.7%; 2019: +19.9%; 2020: +31.2%; 2021: +5.6%; 2022: −26.3%; 2023: −2.6%; 2024: +3.8% +20% 2015 +2% 2016 +34% 2017 +10% 2018 +20% 2019 +31% 2020 +6% 2021 −26% 2022 −3% 2023 +4% 2024
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
PSCH+3.8%+0.6%+8.4%
Health Care Sector median+14.5%+4.2%+7.9%

Source: Fund prospectus, as of Dec 31, 2024

Full PSCH performance history →

What PSCH costs

On a $10,000 investment, PSCH's 0.29% expense ratio costs about $29 a year. The prospectus estimates $368 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.

See the full PSCH fee table →

PSCH top 10 holdings

#Holding% of fund
1Invesco Private Prime Fund21.48%
2Invesco Private Government Fund8.27%
3Molina Healthcare, Inc.4.77%
4BrightSpring Health Services, Inc.4.35%
5Krystal Biotech, Inc.4.25%
6Alkermes PLC3.71%
7Corcept Therapeutics Inc.3.47%
8Glaukos Corp.3.17%
9PTC Therapeutics, Inc.3.16%
10Protagonist Therapeutics, Inc.3.12%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 59.8% of the fund. See all top 25 holdings and asset mix →

Alternatives to PSCH

More funds like PSCH →

PSCH FAQ

What is the expense ratio of PSCH?
PSCH's expense ratio is 0.29%, which works out to about $29 a year for every $10,000 invested. The prospectus estimates total costs of $368 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is PSCH a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 94% of health care sector peers; 5-year return in the bottom quarter of its category; concentrated: top 10 holdings are 59.8% of assets. This is general information, not personalized advice.
What does PSCH hold?
PSCH's largest holdings are Invesco Private Prime Fund (21.5%), Invesco Private Government Fund (8.3%), Molina Healthcare, Inc. (4.8%), BrightSpring Health Services, Inc. (4.4%), Krystal Biotech, Inc. (4.3%). It holds 81 positions in total as of May 31, 2026 (SEC Form N-PORT).
What is PSCH's 5-year return?
PSCH returned +0.6% a year over the five years ending Dec 31, 2024, and +8.4% a year over ten years. Past performance does not guarantee future results.
Who manages PSCH?
PSCH is offered by Invesco through Invesco Exchange-Traded Fund Trust II.